Daniela Matei
Impact in
- Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment
- Oncology top 0.2%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Papers in
- Oncology 73
- PARP inhibition in cancer therapy 22
- Cancer Cells and Metastasis 17
-
- Epigenetics and DNA Methylation 25
- RNA modifications and cancer 20
- Co-authors
- Kenneth P. Nephew (30 shared papers)Ursula A. Matulonis (21 shared papers)Jeanne M. Schilder (14 shared papers)Ignace Vergote (12 shared papers)Werner Meier (12 shared papers)Jonathan A. Ledermann (12 shared papers)Philipp Harter (11 shared papers)Ronnie Shapira‐Frommer (12 shared papers)
- Journals
- Journal of Clinical Oncology (39 papers)Cancer Research (22 papers)Gynecologic Oncology (17 papers)Clinical Cancer Research (10 papers)Oncogene (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Daniela Matei
225 papers receiving 14.1k citations
Daniela Matei's Hit Papers
Peers
Comparison fields: 5 of 145
- Reproductive Medicine 2.9k
- Oncology 5.9k
- Cancer Research 2.7k
- Obstetrics and Gynecology 851
- Molecular Biology 6.1k
Countries citing papers authored by Daniela Matei
This map shows the geographic impact of Daniela Matei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Matei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Matei more than expected).
Fields of papers citing papers by Daniela Matei
This network shows the impact of papers produced by Daniela Matei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Matei. The network helps show where Daniela Matei may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Matei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Hit paper breakdown → | 2012 | 1413 |
| 2 | Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial Hit paper breakdown → | 2014 | 1102 |
| 3 | Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors Hit paper breakdown → | 2008 | 1098 |
| 4 | Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Hit paper breakdown → | 2002 | 510 |
| 5 | Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells Hit paper breakdown → | 2016 | 458 |
| 6 | Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 394 |
| 7 | Targeting Cancer Stemness in the Clinic: From Hype to Hope Hit paper breakdown → | 2018 | 377 |
| 8 | 2016 | 324 | |
| 9 | 2012 | 319 | |
| 10 | Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer Hit paper breakdown → | 2019 | 303 |
| 11 | 2016 | 241 | |
| 12 | 2018 | 208 | |
| 13 | 2006 | 202 | |
| 14 | Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells Hit paper breakdown → | 2022 | 196 |
| 15 | 2011 | 188 | |
| 16 | 2020 | 188 | |
| 17 | 2013 | 168 | |
| 18 | 2012 | 167 | |
| 19 | 2015 | 163 | |
| 20 | 2014 | 155 |
About Daniela Matei
Daniela Matei is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 234 papers that have together received 14.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (52 papers), Epigenetics and DNA Methylation (25 papers), PARP inhibition in cancer therapy (22 papers), RNA modifications and cancer (20 papers), Blood properties and coagulation (19 papers), Endometrial and Cervical Cancer Treatments (18 papers), Cancer Cells and Metastasis (17 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Reproductive Medicine (2.9k citations), Oncology (5.9k citations), Cancer Research (2.7k citations), Obstetrics and Gynecology (851 citations) and Molecular Biology (6.1k citations). Daniela Matei has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kenneth P. Nephew, Ursula A. Matulonis, Jeanne M. Schilder, Ignace Vergote, Werner Meier, Jonathan A. Ledermann, Philipp Harter, Ronnie Shapira‐Frommer, Michael Friedländer and Gordon Rustin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Gynecologic Oncology, Clinical Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.